Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5026-5035

  Boettler, Tobias ^a,c   Choi, Youn Soo ^a   Salek Ardakani, Shahram ^a,d   Cheng, Yang ^a   Moeckel, Friedrich ^a,e   Croft, Michael ^b   Crotty, Shane ^a,c   Von Herrath, Matthias ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e University of Medical School Hamburg Eppendorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD134 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; PRDM1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VIRAL CLEARANCE; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CHLOROCEBUS AETHIOPS; GERMINAL CENTER; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; SIGNAL TRANSDUCTION; VERO CELL LINE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; GERMINAL CENTER; INTERLEUKIN-2; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, OX40; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VERO CELLS; VIRUS REPLICATION;

EID: 84887502545     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300013     Document Type: Article

References (55)

1. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687.
2. Wherry, E. J., S. J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J. N. Blattman, D. L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27:670-684.
3. Tinoco, R., V. Alcalde, Y. Yang, K. Sauer, and E. I. Zuniga. 2009. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 31:145-157.
4. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. Von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203:2461-2472.
5. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12:1301-1309.
6. Elsaesser, H., K. Sauer, and D. G. Brooks. 2009. IL-21 is required to control chronic viral infection. Science 324:1569-1572.
7. Fröhlich, A., J. Kisielow, I. Schmitz, S. Freigang, A. T. Shamshiev, J. Weber, B. J. Marsland, A. Oxenius, and M. Kopf. 2009. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324:1576-1580.
8. Yi, J. S., M. Du, and A. J. Zajac. 2009. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324:1572-1576.
9. Harker, J. A., G. M. Lewis, L. Mack, and E. I. Zuniga. 2011. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334:825-829.
10. Boettler, T., F. Moeckel, Y. Cheng, M. Heeg, S. Salek-Ardakani, S. Crotty, M. Croft, and M. G. Von Herrath. 2012. OX40 facilitates control of a persistent virus infection. PLoS Pathog. 8:e1002913.
11. Croft, M. 2010. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28:57-78.
12. Humphreys, I. R., A. Loewendorf, C. De Trez, K. Schneider, C. A. Benedict, M. W. Munks, C. F. Ware, and M. Croft. 2007. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism. J. Immunol. 179:2195-2202.
13. Sugamura, K., N. Ishii, and A. D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4:420-431.
14. Goulding, J., V. Tahiliani, and S. Salek-Ardakani. 2011. OX40:OX40L axis: emerging targets for improving poxvirus-based CD8 (+) T-cell vaccines against respiratory viruses. Immunol. Rev. 244:149-168.
15. Hirschhorn-Cymerman, D., G. A. Rizzuto, T. Merghoub, A. D. Cohen, F. Avogadri, A. M. Lesokhin, A. D. Weinberg, J. D. Wolchok, and A. N. Houghton. 2009. OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. J. Exp. Med. 206:1103-1116.
16. Salek-Ardakani, S., M. Moutaftsi, A. Sette, and M. Croft. 2011. Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection. J. Virol. 85:9051-9059.
17. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29:1610-1616.
18. Walker, L. S., A. Gulbranson-Judge, S. Flynn, T. Brocker, C. Raykundalia, M. Goodall, R. Förster, M. Lipp, and P. Lane. 1999. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190:1115-1122.
19. Yu, D., and C. G. Vinuesa. 2010. The elusive identity of T follicular helper cells. Trends Immunol. 31:377-383.
20. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura. 1999. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:7058-7066.
21. Bergthaler, A., L. Flatz, A. Verschoor, A. N. Hegazy, M. Holdener, K. Fink, B. Eschli, D. Merkler, R. Sommerstein, E. Horvath, et al. 2009. Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol. 7:e1000080.
22. Fahey, L. M., E. B. Wilson, H. Elsaesser, C. D. Fistonich, D. B. McGavern, and D. G. Brooks. 2011. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J. Exp. Med. 208:987-999.
23. Streeck, H., M. P. D'Souza, D. R. Littman, and S. Crotty. 2013. Harnessing CD4? T cell responses in HIV vaccine development. Nat. Med. 19:143-149.
24. Humphreys, I. R., C. De Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware. 2007. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J. Exp. Med. 204:1217-1225.
25. Salek-Ardakani, S., R. Flynn, R. Arens, H. Yagita, G. L. Smith, J. Borst, S. P. Schoenberger, and M. Croft. 2011. The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J. Clin. Invest. 121:296-307.
26. Choi, Y. S., R. Kageyama, D. Eto, T. C. Escobar, R. J. Johnston, L. Monticelli, C. Lao, and S. Crotty. 2011. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34:932-946.
27. Johnston, R. J., Y. S. Choi, J. A. Diamond, J. A. Yang, and S. Crotty. 2012. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209:243-250.
28. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621-663.
29. Wu-Hsieh, B. A., J. K. Whitmire, R. De Fries, J. S. Lin, M. Matloubian, and R. Ahmed. 2001. Distinct CD8 T cell functions mediate susceptibility to histoplasmosis during chronic viral infection. J. Immunol. 167:4566-4573.
30. Crotty, S., M. M. McCausland, R. D. Aubert, E. J. Wherry, and R. Ahmed. 2006. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood 108:3085-3093.
31. Bresson, D., G. Fousteri, Y. Manenkova, M. Croft, and M. Von Herrath. 2011. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment. J. Autoimmun. 37:342-351.
32. Xiao, X., W. Gong, G. Demirci, W. Liu, S. Spoerl, X. Chu, D. K. Bishop, L. A. Turka, and X. C. Li. 2012. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J. Immunol. 188:892-901.
33. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Höpner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110:1225-1232.
34. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271-275.
35. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206:3015-3029.
36. Johnston, R. J., A. C. Poholek, D. Di Toro, I. Yusuf, D. Eto, B. Barnett, A. L. Dent, J. Craft, and S. Crotty. 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325:1006-1010.
37. Petrovas, C., T. Yamamoto, M. Y. Gerner, K. L. Boswell, K. Wloka, E. C. Smith, D. R. Ambrozak, N. G. Sandler, K. J. Timmer, X. Sun, et al. 2012. CD4 T follicular helper cell dynamics during SIV infection. J. Clin. Invest. 122:3281-3294.
38. Choi, Y. S., J. A. Yang, I. Yusuf, R. J. Johnston, J. Greenbaum, B. Peters, and S. Crotty. 2013. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J. Immunol. 190:4014-4026.
39. Hale, J. S., B. Youngblood, D. R. Latner, A. U. Mohammed, L. Ye, R. S. Akondy, T. Wu, S. S. Iyer, and R. Ahmed. 2013. Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity 38:805-817.
40. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669.
41. Howie, D., S. Okamoto, S. Rietdijk, K. Clarke, N. Wang, C. Gullo, J. P. Bruggeman, S. Manning, A. J. Coyle, E. Greenfield, et al. 2002. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood 100:2899-2907.
42. Lederer, J. A., V. L. Perez, L. Des Roches, S. M. Kim, A. K. Abbas, and A. H. Lichtman. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397-406.
43. Gramaglia, I., A. D. Weinberg, M. Lemon, and M. Croft. 1998. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161:6510-6517.
44. Ballesteros-Tato, A., B. León, B. A. Graf, A. Moquin, P. S. Adams, F. E. Lund, and T. D. Randall. 2012. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36:847-856.
45. Humphreys, I. R., G. Walzl, L. Edwards, A. Rae, S. Hill, and T. Hussell. 2003. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J. Exp. Med. 198:1237-1242.
46. Baumann, R., S. Yousefi, D. Simon, S. Russmann, C. Mueller, and H. U. Simon. 2004. Functional expression of CD134 by neutrophils. Eur. J. Immunol. 34:2268-2275.
47. Diana, J., T. Griseri, S. Lagaye, L. Beaudoin, E. Autrusseau, A. S. Gautron, C. Tomkiewicz, A. Herbelin, R. Barouki, M. Von Herrath, et al. 2009. NKT cellplasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 30:289-299.
48. Gramaglia, I., A. Jember, S. D. Pippig, A. D. Weinberg, N. Killeen, and M. Croft. 2000. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165:3043-3050.
49. Huddleston, C. A., A. D. Weinberg, and D. C. Parker. 2006. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells. Eur. J. Immunol. 36:1093-1103.
50. Williams, C. A., S. E. Murray, A. D. Weinberg, and D. C. Parker. 2007. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet. J. Immunol. 178:7694-7702.
51. Rogers, P. R., J. Song, I. Gramaglia, N. Killeen, and M. Croft. 2001. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15:445-455.
52. Song, J., T. So, M. Cheng, X. Tang, and M. Croft. 2005. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22:621-631.
53. Hirschhorn-Cymerman, D., S. Budhu, S. Kitano, C. Liu, F. Zhao, H. Zhong, A. M. Lesokhin, F. Avogadri-Connors, J. Yuan, Y. Li, et al. 2012. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. J. Exp. Med. 209:2113-2126.
54. Pan, P. Y., Y. Zang, K. Weber, M. L. Meseck, and S. H. Chen. 2002. OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases. Mol. Ther. 6:528-536.
55. Weinberg, A. D., C. Thalhofer, N. Morris, J. M. Walker, D. Seiss, S. Wong, M. K. Axthelm, L. J. Picker, and W. J. Urba. 2006. Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study. J. Immunother. 29:575-585.